Natarajan Sethuraman

Insider Reports History

Entity
Individual
Location
6 Tide Street, Boston, MA
Signature
/s/ Jared Cohen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Natarajan Sethuraman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entrada Therapeutics, Inc. Chief Scientific Officer Common Stock 184K $2.77M $15.09 Sep 9, 2024 Direct
Entrada Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 66.8K Mar 1, 2024 Direct

Insider Reports Filed by Natarajan Sethuraman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRDA Entrada Therapeutics, Inc. Sep 6, 2024 2 -$49K 4 Sep 10, 2024 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Sep 3, 2024 5 -$27.5K 4 Sep 5, 2024 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Jul 12, 2024 2 -$22.3K 4 Jul 16, 2024 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. May 16, 2024 3 -$288K 4 May 20, 2024 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Mar 1, 2024 5 -$28.3K 4 Mar 5, 2024 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Sep 1, 2023 3 -$6.49K 4 Sep 6, 2023 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Jul 10, 2023 2 -$322K 4 Jul 12, 2023 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Apr 17, 2023 1 -$71.3K 4 Apr 19, 2023 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Mar 1, 2023 2 $0 4/A Apr 19, 2023 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Sep 1, 2022 1 $0 4 Sep 6, 2022 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Jul 1, 2022 1 $0 4 Jul 6, 2022 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Mar 1, 2022 2 $0 4 Mar 3, 2022 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 1 $0 4 Nov 1, 2021 Chief Scientific Officer
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 Chief Scientific Officer